These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE). Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395 [TBL] [Abstract][Full Text] [Related]
44. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. Buchanan RM; Arulanandam BP; Metzger DW J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529 [TBL] [Abstract][Full Text] [Related]
45. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population. Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066 [TBL] [Abstract][Full Text] [Related]
46. Antitumor vaccination: where we stand. Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658 [TBL] [Abstract][Full Text] [Related]
51. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Ruffini PA; Neelapu SS; Kwak LW; Biragyn A Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812 [TBL] [Abstract][Full Text] [Related]